With our legacy in the space, we have developed a deep understanding of the needs of healthcare professionals & couples trying to start a family. Today, our curiosity is revolutionizing the fertility community.

Leaders in Fertility

The thought of welcoming a new baby to a loving home is an exciting prospect for many parents. Strollers, birth announcements and baby showers take on new meaning as a sign of the future. But for people struggling to start a family, these cues serve as painful reminders of the one thing they don't yet have. This emotionally uncertain and frustrating journey is more common than many might think; in fact, 1 in 8 U.S. couples experiences difficulty conceiving.1

The good news: there is hope for a number of those couples impacted by infertility. EMD Serono has been a leader in the space, offering drugs, devices, technologies and services to help couples throughout fertility treatment.

Our Fertility Products

More than 20 years ago, we brought to market GONAL-f® (follitropin alfa for injection), one of the first recombinant human products used in the treatment of infertility. We proceeded to build a portfolio of complementary products and devices to use during a fertility treatment cycle, including Ovidrel® PreFilled Syringe (choriogonadotropin alfa injection) and Cetrotide® (cetrorelix acetate for injection).

Important Safety Information

These products should only be prescribed by physicians specializing in fertility or reproductive health. Risks include the following events which can be serious: allergic reactions; ovarian hyperstimulation syndrome (OHSS); lung problems, blood clots, and multiple births. For complete product details about a specific fertility drug, please refer to the Full Prescribing Information for full disclosure.

Caring for the whole patient

With the emotional toll that infertility takes in people's lives, providing resources, information and hope is critical to navigating its challenges. Supporting families impacted by infertility goes beyond medication, which is why EMD Serono created comprehensive programs to help patients access care.

EMD Serono is proud to support people on this journey through personalized emotional support; fertility medication savings through programs like Compassionate Care and Go Direct for eligible patients living with infertility; and educational resources for our family of treatment options.

Caring for the whole patient

Today's world has revealed a need for expanded family building options for many diverse communities, including LGBTQ couples. We're committed to supporting LGBTQ couples by offering relevant resources and collaborating with advocacy groups to improve access to medications.

LGBTQ Parenthood

We’re committed to supporting military personnel with family building options through programs such as Compassionate Corps, which helps eligible, uninsured, medically-retired veterans who have suffered service-related injuries affecting fertility or their spouses.

Compassionate Corps

That’s why we are exploring a scientific partnership model where we will partner with key fertility centers to conduct scientific studies and gather data to assess our technology-focused product portfolio - including Geri® and Gidget® - and determine its optimal value within the marketplace.

We see this as a launching pad for scientific engagement and a new way of exploring our ongoing commitment to the fertility community.

Over time, we hope these technologies will help to improve standardization and consistency and ultimately drive better outcomes for patients facing infertility.


1 RESOLVE, The National Infertility Association. Fast Facts about Infertility. https://resolve.org/infertility-101/what-is-infertility/fast-facts/. Accessed February 15, 2018.


You have accessed https://www.emdserono.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Internet Explorer is not supported

You are using an outdated browser. If you would like to use our website, please use Chrome, Firefox, Safari or other browser

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement